Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes

por Kovatchev, Boris, Meng, Zhaoling, Cali, Anna M. G., Perfetti, Riccardo, Breton, Marc D.
Publicado 2020

Central Role of Fatty Liver in the Pathogenesis of Insulin Resistance in Obese Adolescents

por D'Adamo, Ebe, Cali, Anna M.G., Weiss, Ram, Santoro, Nicola, Pierpont, Bridget, Northrup, Veronika, Caprio, Sonia
Publicado 2010

A post‐hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in individuals with...

por Bolli, Geremia B., Wysham, Carol, Fisher, Miles, Chevalier, Soazig, Cali, Anna M. G., Leroy, Bruno, Riddle, Matthew C.
Publicado 2018

A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the...

por Meneghini, Luigi F., Sullivan, Sean D., Oster, Gerry, Busch, Robert, Cali, Anna M. G., Dauchy, Arnaud, Gill, Jasvinder, Bailey, Timothy S.
Publicado 2020

Primary Defects in β-Cell Function Further Exacerbated by Worsening of Insulin Resistance Mark the Development of Impaired Glucose Tolerance in Obese Adolescents

por Cali, Anna M.G., Man, Chiara Dalla, Cobelli, Claudio, Dziura, James, Seyal, Aisha, Shaw, Melissa, Allen, Karin, Chen, Shu, Caprio, Sonia
Publicado 2009

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment

por Javier Escalada, F., Halimi, Serge, Senior, Peter A., Bonnemaire, Mireille, Cali, Anna M. G., Melas‐Melt, Lydie, Karalliedde, Janaka, Ritzel, Robert A.
Publicado 2018

Interethnic Differences in Muscle, Liver and Abdominal Fat Partitioning in Obese Adolescents

por Liska, David, Dufour, Sylvie, Zern, Tosca L., Taksali, Sara, Calí, Anna M.G., Dziura, James, Shulman, Gerald I., Pierpont, Bridget M., Caprio, Sonia
Publicado 2007

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (ED...

por Roussel, Ronan, d'Emden, Michael C., Fisher, Miles, Ampudia‐Blasco, F. Javier, Stella, Peter, Bizet, Florence, Cali, Anna M. G., Wysham, Carol H.
Publicado 2017

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting

por Meneghini, Luigi F., Mauricio, Didac, Orsi, Emanuela, Lalic, Nebojsa M., Cali, Anna M.G., Westerbacka, Jukka, Stella, Peter, Candelas, DEA, Christophe, Pilorget, Valerie, Perfetti, Riccardo, Khunti, Kamlesh
Publicado 2019

Cellularity and Adipogenic Profile of the Abdominal Subcutaneous Adipose Tissue From Obese Adolescents: Association With Insulin Resistance and Hepatic Steatosis

por Kursawe, Romy, Eszlinger, Markus, Narayan, Deepak, Liu, Teresa, Bazuine, Merlijn, Cali, Anna M.G., D'Adamo, Ebe, Shaw, Melissa, Pierpont, Bridget, Shulman, Gerald I., Cushman, Samuel W., Sherman, Arthur, Caprio, Sonia
Publicado 2010